Regulation of metallothionein synthesis in HeLa cells by heavy metals and glucocorticoids

Journal of Cellular Physiology
M KarinH R Herschman

Abstract

Metallothioneins (MTs) are low molecular weight, cysteine-rich proteins that bind heavy metals. MT induction occurs in liver in response to either heavy metal (Zn++ or Cd++) administration or stress. The synthesis of MT can also be induced by either heavy metals or glucocorticoid hormones in HeLa cells cultured in serum-free medium. Induction of MT by zinc is subject to "desensitization." In contrast, dexamethasone (dex) induction results in a continued elevation in the rate of MT synthesis. The stability of MT is dependent on the availability of metal; consequently, MT induced by dex is degraded much more rapidly (half-life of 11 to 12 hours) than MT induced by elevated zinc levels (half-life of 36 to 38 hours). Removal of either inducer results in biphasic degradation curves, as apothionein and zinc come into balance. In contrast, deinduction kinetics for MT synthesis following removal of the two inducers (zinc and dex) are the same, with a half-life of two and one-half hours. Inhibition of RNA synthesis blocks deinduction after removal of inducer. Induction of MT occurs in a wide variety of species, from blue-green algae to man. This system should provide an excellent model for the comparative biochemistry of regulation of g...Continue Reading

References

Apr 11, 1977·Biochemical and Biophysical Research Communications·K S Squibb, R J Cousins
May 1, 1977·Analytical Biochemistry·J J Sedmak, S E Grossberg
Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C L Chen, P Feigelson
Jul 12, 1979·Biochemical and Biophysical Research Communications·R W OlafsonR G Sim
Jan 1, 1976·Annual Review of Biochemistry·K R Yamamoto, B M Alberts
Feb 1, 1979·Toxicology and Applied Pharmacology·C J Rudd, H R Herschman
Aug 28, 1979·Biochemical and Biophysical Research Communications·K R EtzelR J Cousins
Jun 1, 1978·Archives of Biochemistry and Biophysics·D R WingeK V Rajagopalan
Jun 1, 1978·Toxicology and Applied Pharmacology·C J Rudd, H R Herschman
Dec 18, 1978·Biochimica Et Biophysica Acta·S L FeldmanR J Cousins
Jan 1, 1976·Annual Review of Biochemistry·A L Goldberg, A C St John
Jun 1, 1977·The Journal of Nutrition·M G Cherian
Jun 1, 1975·Hoppe-Seyler's Zeitschrift für physiologische Chemie·R Prinz, U Weser
Jun 16, 1975·Biochemical and Biophysical Research Communications·M P Richards, R J Cousins
Sep 1, 1975·Archives of Biochemistry and Biophysics·D R WingeK V Rajagopalan
Aug 15, 1975·European Journal of Biochemistry·R A Laskey, A D Mills
Nov 1, 1973·European Journal of Biochemistry·U WeserG Jung
Jan 15, 1974·Biochemistry·S E BryanK J Hardy
Sep 15, 1971·Experientia·Z A Shaikh, O J Lucis
May 1, 1970·Toxicology and Applied Pharmacology·J M WiśniewskaM Jakubowski
May 1, 1966·Biochemistry·P PulidoB L Vallee
Feb 12, 1980·Biochemical and Biophysical Research Communications·M KarinD Weinstein
Apr 1, 1980·Journal of Cellular Physiology·M Karin, H R Herschman

❮ Previous
Next ❯

Citations

Nov 1, 1990·Somatic Cell and Molecular Genetics·J Koropatnick, J Pearson
Nov 1, 1993·Biological Trace Element Research·J C AllenL Haedrich
Jan 1, 1989·General Pharmacology·R A AndersenJ Alexander
Dec 1, 1991·Toxicology Letters·S Koizumi, T Sone
Jan 1, 1993·Experimental Gerontology·M C LuceC L Bunn
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·M KarinM C Nguyen-Huu
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·W W Nagel, B L Vallee
Oct 19, 2001·Toxicological Sciences : an Official Journal of the Society of Toxicology·J M DeMoorJ Koropatnick
Sep 17, 2005·American Journal of Respiratory Cell and Molecular Biology·Scott C WesselkamperGeorge D Leikauf
Mar 1, 1984·Environmental Health Perspectives·M Karin, R I Richards
Jun 1, 1990·Proceedings of the Society for Experimental Biology and Medicine·D E LaurinK C Klasing
Dec 1, 1992·Chemico-biological Interactions·A AlboresA J Zelazowski
Mar 15, 1987·Toxicology and Applied Pharmacology·W M Bracken, C D Klaassen
Jan 1, 1985·Chemico-biological Interactions·S KobayashiM Kimura
Apr 1, 1987·Environmental Research·D L Peavy, E J Fairchild
Jun 6, 1998·The Journal of Surgical Research·C SimpkinsS Balderman
Oct 29, 1998·The Journal of Surgical Research·C SimpkinsE Mensah
Apr 8, 2000·Critical Reviews in Biochemistry and Molecular Biology·A T MilesV Rodilla
May 20, 2003·The Journal of Biological Chemistry·Candace StrangPaul J Pfaffinger
Sep 1, 1986·Biochemical Pharmacology·J C Veltman, M D Maines
Oct 1, 1985·Molecular and Cellular Biology·M KarinG Wong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.